Results 101 to 110 of about 287,929 (205)

Treatment of Intracranial Atherosclerotic Stenosis: Current Debates and Future Directions

, 2022
Intracranial atherosclerotic stenosis (ICAS) is a leading cause of ischemic stroke, especially in Asia. Since the publication of high-quality randomized controlled trials conducted by the United States in 2011, ICAS has been a subject of controversy and ...
LUO Jichang, WANG Tao, JIAO Liqun
core   +1 more source

Evaluation of Intensive Statins and Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors on Intracranial Artery Plaque Stability: A Prospective Single‐Arm Study

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Intracranial atherosclerotic stenosis is a leading cause of ischemic stroke and recurrent events due to plaque instability. High‐resolution magnetic resonance imaging identifies plaque enhancement as a key marker of instability.
Weiqi Zeng, Feng Zhou, Hai Zhao, Yukai Wang, Jingjuan Chen, Jiancong Lu, Dezhi Zheng, Jingyun Kuang, Dahua Yuan, Jing Zhou, Changzheng Shi, Xihai Zhao, Xinyi Leng, Bernard Yan, Zefeng Tan   +14 more
doaj   +1 more source

Balloon Angioplasty for Intracranial Atherosclerotic Disease

, 2011
Background and Purpose— Whether stenting is superior to angioplasty in the treatment of intracranial atherosclerotic disease is unknown.
Thanh N. Nguyen, Nauman Tariq, Raul G. Nogueira, Alexander M. Norbash, Osama O. Zaidat, Junaid S. Kalia, Rishi Gupta, Adnan I. Qureshi   +7 more
core   +1 more source

CADASIL with Large Intracranial Arterial Atherosclerotic Stenosis [PDF]

Radiology, 2019
Chen Zhang, Zaiqiang Zhang
openaire   +2 more sources

Wingspan Stenting for Intracranial Atherosclerotic Stenosis

Neurosurgery, 2013
Intracranial atherosclerotic stenosis (ICAS) is responsible for 9% to 37% of ischemic strokes.To evaluate the clinical outcome and risk factors for in-stent restenosis (ISR) after treatment of ICAS with a Wingspan stent.Seventy-seven patients with 79 total target ICAS > 60% (mean, 79.9 ± 8.4%; symptomatic ICAS, 96.2%) underwent attempted treatment with
Yong Sam, Shin, Byung Moon, Kim, Sang Hyun, Suh, Pyoung, Jeon, Dong Joon, Kim, Dong Ik, Kim, Bum-Soo, Kim, Keon Ha, Kim, Ji Hoe, Heo, Hyo Suk, Nam, Young Dae, Kim   +10 more
openaire   +3 more sources

Regional High Wall Shear Stress Associated With Stenosis Regression in Symptomatic Intracranial Atherosclerotic Disease

, 2020
Background and Purpose: Understanding the mechanisms underlying progression/regression of symptomatic intracranial atherosclerotic stenosis (sICAS) will inform secondary prevention of the patients. Focal wall shear stress (WSS) may play an important role,
Ip, Bonaventure, Liebeskind, David, Zeng, Jinsheng, Soo, Yannie, Abrigo, Jill, Ip, Vincent, Leng, Xinyi, Liu, Haipeng; id_orcid, Mok, Vincent, Wong, Lawrence, Fan, Florence, Leung, Thomas, Lan, Linfang, Ma, Sze Ho, Liu, Jia, Ma, Karen, Fan, Yuhua   +16 more
core   +1 more source

Diagnostic performance of coronary CT angiography for stenosis detection according to calcium score: systematic review and meta-analysis [PDF]

, 2012
OBJECTIVES: A systematic review and meta-analysis to assess sensitivity and specificity of coronary CT angiography (CCTA) for significant stenosis at different degrees of coronary calcification.
den Dekker, M.A.M., Vliegenthart, R., Oudkerk, M., de Bock, G.H.; id_orcid, Tio, R.A., Oudkerk, M.; id_orcid, de Smet, K., den Dekker, M.A., de Bock, G.H., den Dekker, Martijn   +9 more
core   +1 more source

Pattern of atherosclerotic carotid stenosis in Korean patients with stroke: Different involvement of intracranial versus extracranial vessels

, 2018
BACKGROUND AND PURPOSE: The clinical pattern of stroke and the angiographic distribution of cerebral atherosclerosis in the Japanese and Chinese are different from those in whites.
임수미
core   +1 more source

Evolocumab Added to Statin Is Associated With Intracranial Atherosclerotic Plaque Regression Compared With Statin Alone

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background We aimed to investigate the effects of evolocumab, a proprotein convertase subtilisin/kexin type‐9 inhibitor for intensive lipid‐lowering, on intracranial atherosclerotic stenosis.
Xinzhi Hu, Yiyang Liu, Weizhuang Yuan, Zongmuyu Zhang, Shun Li, Anqi Cheng, Qiuyu Yu, Haoyao Guo, Yinxi Zou, Mingli Li, Caiyan Liu, Yan Xu, Weihai Xu   +12 more
doaj   +1 more source

Aspirin against Atherosclerotic Intracranial Arterial Stenosis

Journal of Neurology & Neurophysiology, 2016
There is no doubt that atherosclerosis is a chronic inflammatory disease in the inner wall of the arteries caused by the laws of hydrodynamics and environmental chemicals present into the bloodstream. Atheromatous plaques located at the mouths of the perforating and collateral arteries originated from the supraclinoid carotids, distal end of the ...
openaire   +1 more source